STEREOTYPICAL PROLONGED SEIZURES

Clinical trials for STEREOTYPICAL PROLONGED SEIZURES explained in plain language.

Never miss a new study

Get alerted when new STEREOTYPICAL PROLONGED SEIZURES trials appear

Sign up with your email to follow new studies for STEREOTYPICAL PROLONGED SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Inhaled Seizure-Stopper tested in major trial

Disease control Recruiting now

This study is testing a new, fast-acting inhaled form of alprazolam designed to stop prolonged seizures within 90 seconds and prevent them from coming back for several hours. It's for people aged 12 and older with epilepsy who experience these longer seizure episodes. The goal is…

Matched conditions: STEREOTYPICAL PROLONGED SEIZURES

Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

STEREOTYPICAL PROLONGED SEIZURES

Get alerted when new STEREOTYPICAL PROLONGED SEIZURES trials appear

Inhaled Seizure-Stopper tested in major trial